William Blair Weighs in on Henry Schein Inc.’s Q3 2016 Earnings (HSIC)
Henry Schein Inc. (NASDAQ:HSIC) – Investment analysts at William Blair lowered their Q3 2016 earnings estimates for Henry Schein in a research note issued on Monday. William Blair analyst J. Kreger now anticipates that the firm will post earnings of $1.65 per share for the quarter, down from their previous estimate of $1.66. William Blair also issued estimates for Henry Schein’s FY2016 earnings at $6.56 EPS and FY2018 earnings at $7.97 EPS.
Henry Schein (NASDAQ:HSIC) last issued its quarterly earnings results on Thursday, August 4th. The company reported $1.64 EPS for the quarter, beating analysts’ consensus estimates of $1.63 by $0.01. The firm earned $2.87 billion during the quarter, compared to the consensus estimate of $2.85 billion. Henry Schein had a return on equity of 17.84% and a net margin of 4.42%. Henry Schein’s revenue for the quarter was up 9.3% on a year-over-year basis. During the same quarter in the prior year, the business posted $1.46 earnings per share.
A number of other equities analysts have also commented on the company. Zacks Investment Research lowered Henry Schein from a “hold” rating to a “sell” rating in a research note on Monday, August 8th. Goldman Sachs Group Inc. upgraded Henry Schein from a “neutral” rating to a “buy” rating and set a $185.00 price objective on the stock in a research note on Tuesday. Robert W. Baird reiterated an “outperform” rating and issued a $176.00 price objective (up from $175.00) on shares of Henry Schein in a research note on Tuesday, October 4th. Finally, Bank of America Corp. initiated coverage on Henry Schein in a research note on Monday, September 12th. They issued a “buy” rating and a $185.00 price objective on the stock. Six research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. Henry Schein has an average rating of “Buy” and an average target price of $160.50.
Shares of Henry Schein (NASDAQ:HSIC) opened at 158.45 on Wednesday. Henry Schein has a 52 week low of $140.11 and a 52 week high of $183.00. The firm’s 50-day moving average price is $162.49 and its 200 day moving average price is $170.27. The firm has a market cap of $12.96 billion, a PE ratio of 26.84 and a beta of 1.05.
A number of large investors have recently added to or reduced their stakes in the stock. Quadrant Capital Group LLC increased its stake in Henry Schein by 0.4% in the second quarter. Quadrant Capital Group LLC now owns 742 shares of the company’s stock worth $128,000 after buying an additional 3 shares during the last quarter. Montag & Caldwell LLC increased its stake in Henry Schein by 0.3% in the second quarter. Montag & Caldwell LLC now owns 2,700 shares of the company’s stock worth $477,000 after buying an additional 7 shares during the last quarter. Cleararc Capital Inc. increased its stake in Henry Schein by 0.9% in the second quarter. Cleararc Capital Inc. now owns 2,013 shares of the company’s stock worth $356,000 after buying an additional 17 shares during the last quarter. Wetherby Asset Management Inc. increased its stake in Henry Schein by 0.6% in the second quarter. Wetherby Asset Management Inc. now owns 3,350 shares of the company’s stock worth $592,000 after buying an additional 20 shares during the last quarter. Finally, Ranger Investment Management L.P. increased its stake in Henry Schein by 1.5% in the second quarter. Ranger Investment Management L.P. now owns 1,370 shares of the company’s stock worth $242,000 after buying an additional 20 shares during the last quarter. 91.98% of the stock is currently owned by institutional investors.
In related news, Director Paul Brons sold 3,381 shares of Henry Schein stock in a transaction dated Monday, August 29th. The stock was sold at an average price of $164.03, for a total transaction of $554,585.43. Following the sale, the director now directly owns 13,715 shares of the company’s stock, valued at $2,249,671.45. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Corporate insiders own 1.27% of the company’s stock.
Henry Schein Company Profile
Henry Schein, Inc is a provider of health care products and services to office-based dental, animal health and medical practitioners. The Company’s segments include healthcare distribution, and technology and value-added services. The healthcare distribution segment aggregates its global dental, animal health and medical operating segments.
Receive News & Stock Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related stocks with our FREE daily email newsletter.